Tillmann, Bourke W. http://orcid.org/0000-0002-7815-5972
Hallet, Julie
Guttman, Matthew P.
Coburn, Natalie
Chesney, Tyler
Zuckerman, Jesse
Mahar, Alyson
Zuk, Victoria
Chan, Wing C.
Haas, Barbara
Hsu, Amy
Manuel, Douglas
Wright, Frances
Gandell, Dov
Menjak, Ines
Gotlib-Conn, Lesley
Paladino, Grace
Galuzzo, Pietro
,
Funding for this research was provided by:
Sunnybrook AFP Innovation Fund
Ontario Institute for Cancer Research (P.HSR.156)
Article History
Received: 19 March 2021
Accepted: 5 July 2021
First Online: 24 August 2021
Change Date: 24 November 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1245/s10434-021-11006-w
Declarations
:
: JH has received speaking honoraria from Ipsen Biopharmaceuticals Canada, Novartis Oncology, and Advanced Accelerator Applications. NC receives salary support from Cancer Care Ontario as Lead for Patient-Reported Outcomes, and an honorarium from Astra-Zeneca.